NSCLC, gut microbiome, immunotherapy, prospective, Schaalia
NOX1, NOX4, CD47, radiotherapy, YAP1/TEAD4
albumin-bilirubin grading system, immune checkpoint inhibitor, liver metastasis non-small cell lung cancer, prognostic markers
Non-small cell lung cancer, immune checkpoint inhibitor, EGFR, tyrosine kinase inhibitors, lymphocyte subsets model